Royal Bank of Canada »

Catalyst Pharmaceutical Partners shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2011-09-30 $3.0k 2.0k 1.50
2011-06-30 $4.0k 2.0k 2.00

More positions owned by Royal Bank of Canada

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Tc Energy Corp (TRP)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Enbridge (ENB)
Canadian Natural Resources (CNQ)

View all positions for Royal Bank of Canada

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners